Envestnet Asset Management
AMED

Envestnet Asset Management’s Amedisys AMED Stock Holding History

Envestnet Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,512
Closed -$515K – 4048
2023
Q3 		$515K Sell
5,512
-115,711
-95% -$10.7M ﹤0.01% 3237
2023
Q2 		$11.1M Sell
121,223
-7,678
-6% -$630K ﹤0.01% 1243
2023
Q1 		$9.48M Buy
128,901
+11,112
+9% +$961K ﹤0.01% 1267
2022
Q4 		$9.84M Sell
117,789
-17,474
-13% -$1.58M 0.01% 1202
2022
Q3 		$13.1M Sell
135,263
-3,112
-2% -$371K 0.01% 1006
2022
Q2 		$14.5M Sell
138,375
-5,173
-4% -$661K 0.01% 958
2022
Q1 		$24.7M Buy
143,548
+9,223
+7% +$1.38M 0.01% 753
2021
Q4 		$21.7M Buy
134,325
+42,424
+46% +$6.82M 0.01% 807
2021
Q3 		$13.7M Sell
91,901
-9,339
-9% -$1.94M 0.01% 976
2021
Q2 		$24.8M Buy
101,240
+16,422
+19% +$4.31M 0.01% 697
2021
Q1 		$22.5M Buy
84,818
+23,651
+39% +$6.67M 0.01% 678
2020
Q4 		$17.9M Buy
61,167
+12,092
+25% +$3.1M 0.01% 660
2020
Q3 		$11.6M Buy
49,075
+7,589
+18% +$1.73M 0.01% 759
2020
Q2 		$8.24M Buy
41,486
+2,216
+6% +$413K 0.01% 856
2020
Q1 		$7.21M Sell
39,270
-906
-2% -$161K 0.01% 817
2019
Q4 		$6.71M Buy
40,176
+12,112
+43% +$1.8M 0.01% 974
2019
Q3 		$3.68M Sell
28,064
-407
-1% -$53K ﹤0.01% 1219
2019
Q2 		$3.46M Buy
28,471
+24,886
+694% +$2.95M ﹤0.01% 1249
2019
Q1 		$442K Buy
3,585
+1,011
+39% +$127K ﹤0.01% 2419
2018
Q4 		$301K Buy
+2,574
New +$303K ﹤0.01% 2424
2018
Q3 		– Sell
-39
Closed -$3K – 1293
2018
Q2 		$3K Sell
39
-12
-24% -$881 ﹤0.01% 2687
2018
Q1 		$2K Buy
51
+5
+11% +$285 ﹤0.01% 2688
2017
Q4 		$2K Hold
46
– – ﹤0.01% 2823
2017
Q3 		$2K Hold
46
– – ﹤0.01% 2798
2017
Q2 		$2K Buy
46
+7
+18% +$408 ﹤0.01% 2933
2017
Q1 		$2K Hold
39
– – ﹤0.01% 2990
2016
Q4 		$2K Buy
+39
New +$1.66K ﹤0.01% 2972
2015
Q1 		– Sell
-1,041
Closed -$31K – 2028
2014
Q4 		$31K Sell
1,041
-303
-23% -$7.48K ﹤0.01% 1587
2014
Q3 		$27K Buy
1,344
+195
+17% +$3.76K ﹤0.01% 1757
2014
Q2 		$19K Buy
1,149
+224
+24% +$3.17K ﹤0.01% 1772
2014
Q1 		$14K Buy
+925
New +$14.2K ﹤0.01% 1750

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Envestnet Asset Management's AMED Position: Q4 2023 in Review

Envestnet Asset Management sold out of Amedisys (AMED) in Q4 2023, closing a stake of 5,512 shares — an estimated $515K sold.

Envestnet Asset Management first reported a position in AMED in Q1 2014 and held it in 31 quarters. The position peaked at $24.8M in Q2 2021. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Envestnet Asset Management reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 5,512 Amedisys shares in Q4 2023, an estimated $515K.
  • Envestnet Asset Management first reported a position in Amedisys in Q1 2014 and held it in 31 quarters.
  • Envestnet Asset Management's Amedisys position peaked at $24.8M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Envestnet Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.